M&A Deal Summary

Wake Research Associates Acquires Multi-specialty Research Associates

On May 18, 2022, Wake Research Associates acquired life science company Multi-specialty Research Associates

Acquisition Highlights

This is Wake Research Associates’ 3rd transaction in the Life Science sector.
This is Wake Research Associates’ 3rd transaction in the United States.
This is Wake Research Associates’ 1st transaction in Florida.

M&A Deal Summary
Date	2022-05-18
Target	Multi-specialty Research Associates
Sector	Life Science
Buyer(s)	Wake Research Associates
Deal Type	Add-on Acquisition

Target

Multi-specialty Research Associates

Lake City, Florida, United States

Multi-specialty Research Associates serves an an innovator and leader in clinical trials from its office location in north Florida, conducting Phase I-IV clinical trials over a wide range of therapeutic areas, including vaccine research for Covid-19 and other infectious diseases. MSRA works with many leading physicians in the area including neurologists, gastroenterologists, psychiatry, internal medicine, family medicine, OB/Gyn, and ophthalmologists. Furthermore, the experienced staff ensures the highest caliber of patient care, while gathering the most accurate and evaluable data. Multi-specialty Research Associates was formed in 2016 and is based in Lake City, Florida.

Search 214,239 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try Free

Buyer(S) 1

Buyer